XV. Multiple Myeloma and Cell Therapy Workshop

For the first time, due to the COVID pandemic, XV. Multiple Myeloma and III Cell Therapy Workshop will be held in a fully online version, and you are all invited!

We are happy to announce the XV. Multiple Myeloma & III. Cell therapy workshop on 12.11.2020 and we would like to invite you to follow the workshop, on 12 November 2020 from 9:30 AM CET at the following YouTube link: https://youtu.be/8WyM-UD0e4g 

Unfortunately, due to the COVID pandemic situation, the regular Multiple Myeloma & Cell Therapy Workshop, which always takes place in the autumn, this year will be held in a fully online version. 

During the session, you can ask questions via the sli.do page, by entering the event code:  myeloma

However, you can join the workshop at any moment, and the workshop will be available even after the event for future viewers.

The program this year will have four major sections: 

  1. Genomics of monoclonal gammopathies

  2. Novel molecular aspects in MM biology and therapy

  3. In vivo models and CD38 in MM

  4. Cell-based therapy section

  5. Here all the details of the conference:

The program :

9:30 – 9:40
R.Hájek / M.Šimíček

Genomics of monoclonal gammopathies

9:45 – 10:00
Genomics of minimal residual disease in MM
10:05 – 10:25

Genomics in MM extramedullary disease
10:30 - 11:00 Break

Novel molecular aspects in MM biology and therapy

11:00 – 11:20
Proteasome inhibitor resistence in MM: a lesson from imunoglobulin synthesis

11:25 – 11:35
Novel factors regulating Ig production in plasma cells

11:40 – 11:55
Analysis of MyD88 signalosome driving human lymphomas
12:00 - 13:00 Break

In vivo models and CD38 in MM

13:00 – 13:15
Mouse models in hematooncology

13:20 – 13:35
Many aspects of CD38 targetability in MM

13:40 – 13:55
Daratumumab in MM extramedullary disease
14:00 - 14:30 Break

Cell-based therapy section

14:30 – 14:45
P. Celichowski
Immunotherapy with universal T cells

14:50 – 15:05
Allogeneic NK cells for cancer treatment

15:10 – 15:25
NK cell therapy - results of clinical trials

15:30 – 15:45
Follow-up ALA genomics project - review and project design

B.Wingham (IsoPlexis)
Functional Immune Phenotyping

16:10 – 16:30
Open discussion

16:35 – 16:40
R.Hájek / M.Šimíček
Concluding remarks

We are looking forward to a virtual meeting with you!


Professional guarantor of the program:
RNDr. Michal Simicek, PhD. 

Seminar secretariat:
Jan Lapes
mobile: +420 734 338 328
email: lapes@hanzo.cz



Workshop partners

Celgene Janssen Spadia

Projekt OP VVV Nové směry biomedicínského výzkumu na Ostravsku, reg.č. CZ.02.1.01/0.0/0.0/18_069/0010060 byl podporován z Evropských strukturálních a investičních fondů